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ABSTRACT
CHARACTERIZING THE ACTIVITY OF ANTIMICROBIAL PEPTIDES
AGAINST THE PATHOGENIC BACTERIUM CLOSTRIDIUM DIFFICILE IN
ANAEROBIC ENVIRONMENT
Adenrele Mojeed Oludiran
Old Dominion University, 2018
Director: Dr. Purcell Erin

Clostridium difficile is an anaerobic Gram-positive pathogen with high treatment costs and
mortality and very high antibiotic tolerance. Antimicrobial host-defense peptides (HDPs)
produced naturally by animal immune systems are promising candidates to develop novel therapies
for bacterial infection because they cause oxidative stress that damages multiple targets in bacterial
cells, so it is difficult for bacteria to evolve resistance to these attacks.
Piscidins, fish-derived HDPs that can also form complexes with copper (Cu) to enhance
their activities, are very active against multiple bacterial species in an aerobic environment. We
examined their activity against C. difficile and other species in an anaerobic environment and found
that the interaction of piscidins and copper is different in different oxygen environments. Piscidins
are highly active against C. difficile and could be a good candidate for drug development.
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CHAPTER 1
INTRODUCTION
Combating harmful bacterial infection is a complex process that requires a sophisticated
and diligent approach, especially when it involves Clostridium difficile bacteria (Figure 1).
Clostridium difficile is a Gram-positive anaerobic spore producing bacterium, found in the
intestine of many animals and humans. Imbalance to the commensal microbiota due to antibiotic
treatment, is the major risk factor in Clostridium difficile infection (CDI) after exposure to C.
difficile spores (1). The longitudinal section of C. difficile bacterium is shown in Figure 1

Figure 1: The longitudinal section of Clostridium difficile bacterium. Shown are the vegetative cell, the
peptidoglycan capsule which absorbs Gram stain, and daughter which has differentiated into spore.
Image adapted from Jane Hartman (trilobiteglasswork) Etsy.com

This thesis is format after FEBS Journal (2017) Federation of European Biochemical Societies
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The Clostridium difficile life cycle has two main stages. Metabolically dormant C. difficile
spores persist in the environment and germinate if and only if they are ingested by a susceptible
host (36). Clostridium difficile infection (CDI) is a consequence of exposure to C. difficile spores
which germinate in the digestive tract to form the vegetative cells. Vegetative cells are the
replicative form that produced the toxin, causes disease symptoms and can germinate into new
spores to spread the infection into new host (33). C. difficile toxins disrupt host cell-cell junctions
in the epithelium, which results in CDI symptoms, including fever, diarrhea, stomach pain, nausea,
enlargement of colon and death in humans (2). CDI is associated with more than 20% of hospitalacquired diarrhea cases in United State (3). It costs more than $5billion yearly to treat and up to
45,000 lives are lost annually in United States alone (3).
CDI is resistant to multiple classes of antibiotics and has a 15 – 26% recurrence rate after
treatment (4-6). When humans are exposed to pathogens the first line of defense is the innate
immune system, which releases reactive oxygen species (ROS) and cationic antimicrobial host
defense peptides (HDPs) to kill foreign cells. These antimicrobial peptides can kill bacterial cells
through a variety of mechanisms, attacking the cell membrane and/or intracellular targets (37-39).
More than 2700 of these peptides has been discovered in different families but, this research is
focused on the specific family called piscidins (18). Piscidins are derived from fish (hybrid striped
bass) mast cells and play very significant role in antimicrobial defense in the fish innate immune
system and are occasionally part of adaptive immune responses as well (25), piscidin-1 (p1) and
piscidin-3 (p3) are the two antimicrobial peptides which play important role in this study.
These two peptides are intrinsically disordered in solution and contain a high number of
hydrophobic amino acids (26). They differ in their antimicrobial mechanisms with p1 targeting the
bacterial membrane and p3 showing a strong intracellular nuclease activity (26 & 27).
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The piscidins each contain 22 amino acids residues, of which about 60% are hydrophobic
in nature, and conserved amino terminal regions. Figure 2 showed conserved region and conserved
amino acid residue in these peptides p1 (PDB ID 2OJM) and p3 (PDB ID 2MCX) respectively.

2MCX:A|PDBID|CHAIN|SEQUENCE
2OJM:A|PDBID|CHAIN|SEQUENCE

FIHHIFRGIVHAGRSIGRFLTGX
FFHHIFRGIVHVGKTIHRLVTG*:*********.*.:* *::**

Figure 2: The amino acid residues conserved in p1 & p3. The three underlined
N-terminal amino acid residues represent the ATCUN region for binding of Cu2+
and Ni2+ respectively.

This conserved region can bind some transition metals (like copper(II) and nickel(II)) and
is called the amino terminal copper and nickel binding (ATCUN). The ATCUN regions for p1 and
p3 are FHH and FIH amino acid residues respectively. The two piscidins fold into alpha helical
secondary structure but are inherently stable (28). The piscidin-3 peptide structure is shown in the
Figure 3 below.

Figure 3: PDB CODE: 2MCX. The α-Helix structure of piscidin-3 found by solidstate NMR. Figure adapted from pymol protein structure software.
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The transition metals copper has well-known antimicrobial metallic properties. It has
bactericidal effect in its ground state (Cu) and in multiple ionic state, most commonly Cu(I) and
Cu(II) (29 & 30). The capability of this transition metal to act as an antimicrobial agent alone or
coordinate to other ligands to form different complexes are exploited by many scientific studies
(29). Recently, Cu and its complexes are used in water purification and hospital waste
management.
Today, much scientific research support copper been algaecide, fungicide, nematicide,
antimicrobial and antifouling agent respectively (29 & 31).
In the +2 oxidation states (Cu(II) [Ar] 4s0 3d9), copper can coordinate up to six bonds
resulting into an octahedral shape, which is very useful in the formation of many complexes. The
p1 and p3 ATCUN motifs have been shown to bind Cu2+ in a 1:1 stoichiometric measurement with
Nano molar affinity (31). At the ATCUN amino acid residues, Cu2+ binds directly to the two
subsequent backbone amide nitrogen and the terminal nitrogen on the conserved histidine of the
peptides (32). These two disordered peptides show high antimicrobial activity against a variety of
pathogenic bacteria (31).
Both peptides inhibit bacterial growth, kill actively growing bacterial, and can disperse
bacterial biofilm (28). The efficacy of both peptides is enhanced by Cu2+ binding (31 & 43). The
production of reactive oxygen species (ROS) in the presence of these peptides when planktonic
bacteria are exposed to them create an imbalance between ROS and the bacterial defense, leading
to high oxidative stress experienced, either at the membrane (leading to membrane disruption) or
covalent DNA damage (nuclease activity) (40, 41 & 42). The peptides performance in an anaerobic
environment have yet to be tested, but HDPs have shown to have antimicrobial activities in all
parties of the body tissues including anaerobic ones.
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So, this work examines the effect of HDPs (piscidins and their complexes) on Clostridium
difficile in an anaerobic environment. Piscidin activity is assessed against C. difficile, an obligate
anaerobic bacterium, and Escherichia coli and Pseudomonas aeruginosa facultative anaerobes
capable of living in aerobic and anaerobic environments. The methods applied for combating these
bacteria started from the measurement of minimal inhibitory concentration (MIC), the peptide
concentration required to inhibit the bacterial growth called minimal inhibitory concentration
(MIC) peptide concentration required to inhibit the bacterial growth (44). Time kill assays,
determined the rate of peptides killing of C. difficile vegetative cells and the amount of biofilm
formed in the presence of peptides, their copper complexes and transition metals alone are
measured (31). The method helps to elucidate the antibiofilm properties of piscidins on C. difficile
and oxidative response of the bacteria to transition metals.
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CHAPTER 2
LITERATURE REVIEW
2.1 INNATE IMMUNE SYSTEM AND OXIDATIVE STRESS
The innate immune system, also known as the first line of immunological defense in
advanced organisms, is fast and has having multiple mechanisms to attack pathogens. This protects
host organisms (higher animals) from foreign pathogens, before the more comprehensive adaptive
immune system is activated (51). Infection recognition is a complex process initiated by the
pathogen’s production of specific molecules called pathogen-associated molecular patterns
(PAMPs) which are sensed by host pathogen recognition receptors (PPRs). This triggers the innate
immune system to release a series of anti-pathogens substances like host defense peptides (HDPs),
cytokines, chemokines and sometimes type1 interferons (52). Some of the innate immune system
molecules generate reactive oxygen species (ROS) and /or reactive nitrogen species (RNS) to help
combat the harmful microbial cells (54).
Oxidative stress is the disturbance in the balance between the production of reactive oxygen
species (ROS) and antioxidant defenses in organisms’ system. Oxidative stress is known to be “the
imbalance that exist between oxidation and antioxidation in a system, in which oxidation exceed
the counter effect of the system” (46). Oxidative stress in the system is a very detrimental process
because it results in the damage including DNA mutation, lipid peroxidation, and oxidation of
membrane layers. It is also employed by the body’s innate immune system sometimes to combat
foreign bodies (46). Oxidative stress is well documented in many organisms. It can occur in
different parts of many systems and they are implicated in many heavy metal ions’ toxicities
because transition metals can change their oxidation state, serving as electron donors (47).

7

2.2 METAL ION INDUCED OXIDATIVE STRESS
Transition metals can induce oxidative stress due to the ability to change their oxidation
states (50). Gallego et al conducted a study which involved the treatment of plant leaves with
0.5m of Fe(II), Cu(II) or Cd(II) ions. Their study showed that after incubation, chlorophyll and
glutathione (GSH), activity decreased but peroxidation and lipoxygenase activity increased. This
result concluded that excess ions of these metals created oxidative stress for the plant leaves’ cells
(47).
Copper(II), or cupric ion, is the form of copper most likely to induce oxidative stress via
its reduction to Cu(I) (cuprous ion) in a biological system, when in the presence of a strong
reductant. Scheme 1 shows that this process results in the decomposition of hydrogen peroxide
through the Fenton reaction process. Cupric ion does not cause oxidative stress directly. Instead,
the (free radicals and reactive hydroxide ions generated in these reactions, cause the oxidative
damage to biological molecules) (48).
More evidence demonstrated how metallic-induced oxidative stress through a
multifunctional mechanistic process decomposed hydrogen peroxide (49). The result of that study
also identified an indirect mechanism, sulfhydryl reserves which was hypothesized to be by redoxinactive metals (50). Many transition metals induce their form of oxidative stress because they can
easily change their oxidation states (50).

Scheme 1: Cu(II) production of both free radical and ionic hydroxide in the presence
hydrogen peroxide via Fenton reaction
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2.3 HOST-DEFENSE PEPTIDES (HDPs) INDUCED OXIDATIVE STRESS
The elevation of reactive oxygen species (ROS) in the host cell’s physiology can either aid
pathological processes by bacteria or kill the bacteria by host deference systems (53). Many hostdefense peptides combat bacteria by introducing oxidative stress on bacterial cell surfaces or in
the bacterial cytoplasm (54). The innate immune systems produce these host-defense peptides to
act as broad-spectrum antimicrobial agents in the body (18 & 31).
HDPs in the innate immune system have immunomodulatory activities, apart from acting
directly as antimicrobial peptides (18). That is, they can also recruit leukocytes to the site of
infection, suppress the potentially harmful inflammatory responses, stimulate angiogenesis and
wound healing (55), because of all these functions include upregulation of chemokines (a group
very small proteins that attract T-cells to site of injury) production. HDPs are ubiquitous in all
complex organisms’ innate and sometime adaptive immune system. As such they are strong
candidate for new antimicrobial drugs. Figure 4 shows how these peptides can directly attack the
membranes of bacteria (like membrane targeting piscidin p1) or target the intracellular DNA of
the bacteria (piscidin p3) with nuclease activities (55, 56 & 57).
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Figure 4: The illustration of biological roles of HDPs by innate immune modulation,
peptides direct killings and intracellular target killings. Adapted from Robert E. W. Hancock &
Hans-George Sahl 2006.

2.4 PISCIDINS AND THEIR METAL COMPLEXES
Piscidin are a prominent family of HDPs first discovered in the mast cells of vertebrates
(31). These broad-spectrum antimicrobial peptides were isolated in hybrid bass striped fish
(Morone saxatilis) and NMR studies suggest that they are intrinsically disordered in solution but
adopt an amphipathic α-helix structural conformation when bound to model membranes (31 & 58).
Piscidins can be isolated from other fish species and their ubiquity can be justified in fish because,
fish are constantly exposed to pathogens (59 & 60).
The piscidin focused on in this investigation are p1 and p3 respectively. They are
bactericidal in nature, but their mechanisms of action are different (31).
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These

two

peptides

(p1:

FFHHIFRGIVHVGKTIHRLVTG

and

p3:

FIHHIFRGIVHAGRSIGRFLTG), are intrinsically disordered in solution. This is likely due to
the high numbers of hydrophobic amino acid residues in these peptides, compared to the
hydrophilic residues. p1 & p3 are isoforms of one another with similarities and variations in their
biological activities, specifically varying where they attack bacteria (i.e., p1 attacks the cell
membrane and p3 the DNA) (26-31).
The overall positive charge in the piscidin peptides’ amino acid residues helps them to
interact with the phospholipids of the cell membrane and/or the acidic backbone of DNA, causing
reactive oxygen production that leads to oxidative stress within the cell bilayer membrane (26).
Piscidins also employ the same method in the intracellular targets, and they can be self-promoting,
inserting themselves into the bilayer cell membrane and interrupting the membrane integrity (55).
2.5 OXIDATIVE STRESS RESPONSE IN BACTERIA
Bacteria use different methods to respond to oxidative stressors encountered in their
environment from various sources like drugs, metals, nutrients, host defense system and sometimes
UV-radiation (62 &63). The nutrient in their surroundings are both helpful and harmful,
particularly those that create imbalance in their oxidative environment (62). In some cases, the
oxidative stress experienced by bacteria are because of ROS, and RNS (63). Some well-known
oxidative stress responses in bacteria during anomalous growth process are of two main types’
gene regulation and/or repair responses (62).
The oxidative stress gene regulation response is the production or increased activity rate of
antioxidant enzymes or proteins (like the OxyR system for hydrogen peroxides and the SoxRS
system for superoxide) in bacteria (65). The OxyR and SoxRS system for regulation of oxidative
stress created by ROS and others are said to be conserved in both Gram-positive and Gramnegative bacteria (66).
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The repair response is focused primarily on DNA either by exertion or methylation repair
methods of the bacteria genes (64). Some bacteria have other response to oxidative stress or
extracellular stress in general, including the production of biofilm.
2.6 BIOFILM AS STRESS RESPONSE
Biofilms are structured multicellular communities of microorganisms that adhere to
surfaces (67). Bacteria biofilm are associated with more than 65% of infections and recurrent
infections in hospitalized patient in the United States of America alone and lead to high rate of
chronic diseases in humans’ health around the globe (67 &68). Biofilm containing multiple or
single bacteria taxa, are mostly composed of a secreted exopolysaccharide matrix which protect
the cells within the biofilm from extracellular stress, including antibiotics (76) Cells in a biofilm
can be up to 1000-fold more resistant to antibiotics than cells of the same bacterial species outside
of a biofilm (69). Growth in a biofilm also leads to changes in bacterial metabolism and gene
expression (66).
Hundreds of genes are responsible for stress associated biofilm formation in bacteria. One
example is the MqsA/MqsR pair of genes in E. coli that induce biofilm formation in response to
toxin stress has antitoxin stress (70). Biofilm production has been reported as a direct response to
antibiotic stress (71). In May 2014, Cesar and colleagues implicated biofilm formation as part of
stress response to antimicrobial peptides (68).
2.7 OXIDATIVE STRESS RESPONSE IN BACTERIA
The oxidative stress experienced in both aerobic and anaerobic bacteria differ because of
the availability of oxygen. While aerobes make use of oxygen to produce energy, ROS are also
produced as by-products that can be harmful to their cells (72). Anaerobes also experience
oxidative stress. Since this stress is not only external or extracellular based only, ROS can also be
generated intracellularly (62).
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2.8 OXIDATIVE STRESS RESPONSE IN AEROBIC BACTERIA
Aerobic bacteria that use oxygen in respiration can also create “ROS” and RNS, which
leads to oxidative stress (62). The response of bacteria to this type of stress is the production of
antioxidant enzymes (62). The innate immune system also adopts this strategy against foreign
bodies through the production of different molecules or peptides that initiate or induce a process
called the “oxidative burst” (51-54 & 62). Some of the antioxidant enzymes used by the bacteria
are superoxide dismutase (SOD), catalase, alkylhydroperoxidaes, superoxide reductase and
peroxidase. The co-factor for most of those antioxidant enzymes is iron. Iron can absorb the
electrons that make ROS reactive, but excess iron can also result in metallic ion oxidative stress
for the bacteria (62).
Pseudomonas aeruginosa and Escherichia coli are facultative anaerobes that can live in
the presence of absence of oxygen. Pseudomonas aeruginosa is a Gram-negative bacterium that
can be a life-threatening with strong resistance to antibiotics (8). The model P. aeruginosa strain,
PA01, was isolated from a wound, while other strains were found in from burns and cystic fibrosis
(9 & 10).
P. aeruginosa, is an opportunistic, infectious bacterium that causes chronic infection in
patients who already have cystic fibrosis, increasing their mortality rates (12 & 13). This
opportunistic pathogen, well-known for its large biofilm formation also causes chronic biofilm
infection and has ability to form three exopolysaccharides types of biofilm (14 &15). The high rate
of infection by P. aeruginosa, has been traced back to the bacteria ability to grow and flourish
easily in sputum, found in large volume along the human airways. So, in the case of cystic fibrosis
of the lungs (CF Lungs) they can be easily determined in the sputum after 50 minutes of infection
(16 & 17). Unlike E. coli, Pseudomonas aeruginosa (PA01) makes use of many genes and complex
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way of responding to oxidative stress, including formation of large amounts of biofilm. P.
aeruginosa PA01 exhibits high rates of biofilm formation and copper-piscidin complexes have
been previously demonstrated to disperse PA01 biofilms (31).
PA01 genes that combat oxidative stress are katB-ankB, ahpB and ahpC-ahpF (73). Invitro the katB-lacZ reporter expression level increased 250-folds when cells were exposed to
oxidative generating compounds (H2O2-generating compounds) (73). Both anhB-lacZ and ahplacZ expression level increased by 90 and 3 folds respectively when the bacteria are induced by
paraquat (an oxidative generating compound), within 5 minutes (73).
The mutant PA01 (∆oxyR) does not express those genes mentioned before when exposed
to either of the oxidative generating compounds above and any other form of oxidative stress
because exposure to the same compounds kill the mutant before gene expression can change.
They are highly susceptible to oxidative stress but, none of the oxidative stress genes get expressed.
What was inferred from this was that oxyR is responsible for the control of oxidative stress
response genes and those genes are used to counter the effect of oxidative stress in P. aeruginosa
(62, 70 – 73).
Escherichia coli is a known Gram-negative bacterium and widely spread in food, water
and air contamination (19). E. coli can live aerobically or anaerobically and responds to oxidative
stress by two well documented strategies of antioxidant enzyme formation and DNA-repair protein
formation, as well as biofilm formation as a result of oxidative stress (68, 70 & 71).
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2.9 OBLIGATE ANAEROBE
Clostridium difficile is the only obligate anaerobic microbe principally investigated in this
research.

Figure 5: The life cycle of Clostridium difficile. Adapted from Karissa Culbreath et al. Journal of
clinical microbiology, Oct. 2010, p. 3738–3741

This bacterium is a flagellated, Gram-positive rod-like (bacillus), and has two states in its
life cycle (1). Dormant non-metabolizing spore are resistant to oxygen, alcohol, and other stresses.
Spores let the bacteria spread through the oxygenated environment to new hosts (34). The actively
germinating phase that can produce spores and cause infection through the production of exotoxin
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in C. difficile life cycle the vegetative cells (3 & 75). This destructive phase is the main target of
this investigation. The vegetative cells highly antibiotic resistant, and they form biofilm. Their
biofilm in the hypervirulent strains aid in the bacteria protection and infection processes (1-7 &33).
All the life cycle stages are described in Figure 5 (1, 2 & 75).
2.10 C. DIFFICILE VEGETATIVE CELLS AND PATHOGENESIS
C. difficile is the causative agent of hospital related antibiotic-associated diarrhea and
pseudomembranous colitis (1 & 2). The bacteria produce two main toxins in the intestine called
toxin A (Ted A) and toxin B (Ted B), some strains of C. difficile also produce a third type of toxin
called binary toxin (CDT) (74).
The pathogenesis of this bacterium starts from the vegetative cell production of toxin after
colonization of the animal gut (33). When the innate immune response of the host cells fails,
bacteria colonization increases, and disease symptoms set in, shown in the figure 6 flow chart.
Unless the antitoxin treatment works, or vegetative cells are killed off before toxin production, the
symptoms rapidly surface in the infected individual (75). The major risk factor which increases
susceptibility to CDI is the disruption of microbiota intestinal community is antibiotics and others
are secondary to antibiotics (33 &75).

16

Figure 6: Pathogenesis of Clostridium difficile Infection. Chart adapted from Daniel A.
Leffler and J. Thomas Lamont N Engl J Med 2015;372: 1539-48
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2.11 C. DIFFICILE AND ANTIMICROBIAL AGENTS
Treatment with fluoroquinolone antibiotics results in the disruption of microbiota
communities that normally out-compete C. difficile for nutrients and allows C. difficile
colonization and CDI associated diarrhea with roughly 33% recurrence after treatment (34). The
antibiotic was meant to fight microorganisms but in doing so, it created an environment susceptible
to the C. difficile infection, Jacques Pepin et al have found similar results with the antibiotic
metronidazole used to treat recurrent CDI; 33.3% of patients had a second recurrence after
metronidazole treatment (34). Both studies not only point out that antibiotics have not been
effective against C. difficile, but also indicate promotion of adaptive C. difficile strains in the toxins
production by this pathogen [5 &34]. According to the medical community of the early 1980s the
use of metronidazole and vancomycin were effective antibiotics against C. difficile, but in recent
years, the high rate of recurrence, despite the usage of those antibiotics, is not just anomaly it is a
serious and an ongoing problem (34 & 35).
The Center for Disease Control and Prevention (CDC) warned against the usage of those
two antibiotics in treatment of Clostridium difficile-associated disease (CDAD) to avoid
vancomycin resistant enterococci and staphylococci bacterial infections. This reduced the
confidence level in these antibiotics and set stage for a new and urgent need for antimicrobial drugs
[35]. Another study by Hetch D W. and Galang M. A et al, used 15 well-known antibiotics against,
110 toxigenic clinical strains of C. difficile to check effectiveness. This study came about as a
result of the decrease in confidence in the use of antibiotics against this bacterium. Yet, none of
the 15 antibiotics were able to kill the strains of Clostridium difficile in-vitro. Table 1 shows the
distribution test of all the antimicrobial agents tested on isolated clinical C. difficile strains [35].

18
Table 1: Distribution of antimicrobials tested against 110 toxigenic clinical C. difficile isolates

In view of this looming antimicrobial failure, we turn to naturally occurring antimicrobial
peptides, HDPs. These peptides, as already discussed, channel oxidative stress that they create
against bacteria cells to kill them (30 &31). The peptides alone, their complexes and sometime
copper alone can generate diverse oxidative stress, which can quickly overwhelm the bacteria cells,
resistance will not easily be develop against them. Moreover, it is possible that as the piscidin are
naturally produced in organisms’ immune systems, health challenges posed by them may be low.
2. 12 OXIDATIVE STRESS RESPONSE IN C. DIFFICILE
C. difficile an anaerobic bacterium but, can survive oxygen level up to around 2%. So, C.
difficile must have mechanisms of defense to tolerate oxygen molecule and ROS generated as a
result of responding to oxidative stress from these oxygen molecules as well as antimicrobial

19

peptide peptides and metal ions (77). Aside the endogenous ROS that might be produced during
metabolic reactions of the bacteria. Antimicrobial peptides, metal ions and oxygen molecules can
aggravate the situation (49 & 56).
In C. difficile the oxidative stress response has yet to be well established, although ROS
scavenging enzymes like catalase, peroxidase and superoxide dismutase (SOD) have been
identified being identify on their spores. The vegetative cells’ defense against oxidative stress
require more intensive investigation because reports on this aspect of bacterial physiology are not
yet sufficient. A conserved putative superoxide reductase (SOR) is also encoded in the C. difficile
genome and expressed in transcriptomic and proteomic studies of vegetative cells (80).

The

sensitive of C. difficile to piscidin peptides and complexes with the oxidative stress response of
this bacterium to metal ions are reported in these investigations.
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CHAPTER 3
RESEACH OBJECTIVES
The advent of failure in many strong antibiotics against the Clostridium difficile and the
fast adaptation of the bacteria to them, there is urgent need for antimicrobial agents that can kill
and minimize the adaptation of the bacteria to them. Oxidative stress adaptation in bacteria are
difficult because it can come from diverse sources, like transition metal ions and antimicrobial
peptides produced by animal immune systems. The objective of this research is to:
1. Characterize the oxidative stress response of C. difficile to antimicrobial peptides and
transition metals
2. Determine the effect of antimicrobial peptides in the aerobic and anaerobic
environments
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CHAPTER 4
EXPERIMENNTAL PROCEDURE
4.1 MATERIAL AND SAMPLES
LB-broth, Agar, Bacto yeast extract, BHI (Brain-Heart Infusion), Glucose, drugs are Host
defense peptides (HDPs) piscidin-1 (p1), piscidin-3 (p3), CuSO4, CuCl2 and Cu(NO3)2 (Cu2+) and
piscidin complexes. Piscidins and complexes were provided by the Cotton lab (William and Mary).
Na2PO4, Nuclease free water, TY-media, dry ice, 630 ∆erm Clostridium difficile strain (lab strain),
R20291 Clostridium difficile strain (virulent strain), Escherichia coli (DH5 alpha Lab strain from
New England Biolabs, PDJ1 and MWF1 two gift strains from Liberdo lab) and Pseudomonas
aeruginosa (PA01 strain). 1×PBS, 1% crystal violet, variable percentage of Ethanol Antibiotics
(Ampicillin and Kanamycin). Unless otherwise specified, reagents were purchased from Fisher
scientific.
4.2 INSTRUMENTATIONS
Centrifuge (1) Accuspin micro 17 (Fisher Scientific) (2) Legend micro 21R
(Thermoscientific), Imaging is through syngene image (U); Genius 3. Optical density (OD); (1)
Genesys ws UV-Vis spectrophotometer (Thermoscientific) (2) Smart Bio drop (Dr. Pascal’s lab)
(3) Ultraspec 10 (Bio-Rad), Anaerobic chamber (Coy laboratories), Incubator and sample shaker
Max Q 6000 by (Thermoscientific), Dry and wet bath (Thermoscientific and Corning/LSE).
Fluorescence UV-Vis spectrophotometer plate reader (Bio-Tek) and smart pH-meter
(SevenCompact).
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4.3 MINIMAL INHIBITORY CONCENTRATIONS (MIC)
4.4 MIC FOR P1 AND P3
The minimal inhibitory concentrations MIC for p1 and p3 was verified for both ∆erm 630
strain and virulent strain of R20291 respectively. Four biologicals of both C. difficile. Strains were
cultured in TY-media for 24hrs at 370C in the anaerobic chamber’s incubator using glass test tubes.
After 24hrs these cultures were used to inoculate fresh culture in 96 well plates, leaving the first
and last columns in the plate full of non-inoculated medium as blanks. Each experimental well
contained peptide and /or copper at the indicated concentration and the total volume /well was
constant at 200µl, with volume adjusted as needed with nuclease free water. Inoculated plates were
incubated at 370C for 16 hours.
After 16 hours plates were taken out of the chamber, plate exteriors were sterilized with
bleach, and plates were read at 630/nm excitation wavelength in Bio-Tek plate reader. The 96 well
plates used for these experiments has been deoxygenated in the anaerobic chamber for more than
72hours before usage.
4.5 MIC FOR Cu2+ CONCENTRATIONS
Four fresh cultures of the two C. difficile. Strains (R20291 and 630∆erm) were inoculated
from overnight in 96 well plates with TY medium containing copper ion in a gradient concentration
from 64uM to 0.5uM incubated and measured as described above. We employed three different
strains of E, coli (DH5α, PDJ1, and MWF1 respectively) to establish the piscidin MICs for them
in the presence and absent of oxygen. Anaerobic cultures were grown in the incubator in the
anaerobic chamber and aerobic cultures were grown in a laboratory incubator. We maintained the
same MICs growth assay steps and setup already discussed above and after 16 hours growth data
was obtained with the plate reader.
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4.6 BIOFILM ASSAY
4.7 P1 AND P3 BIOFILM ASSAY
We grew four biologically independent cultures of R20291 and inoculated 2 mL/well of
BHIS media supplemented in 1% glucose and 50 mM Na2PO3 pH 7.4 with 20µL of saturated
culture in 24 well plates. Culture were incubated for 2 hours before treatment and left in incubator
at 370C for 24 hours. Plates were degassed in the anaerobic chamber for 72 hours before using.
Biofilm cultures contained piscidin and/or copper at the indicated concentrations. After 24 hours
of growth, cell density measured at 630 nm. Afterwards, non-adhered cells were removed so
biofilm could be measured.
Carefully slant the 24 well plates to remove the media without allowing the pipette tips to
touch the bottom part of the wells. Wash the left over in each well with 1×PBS, 1ml for each well,
pouring the wash buffer gently and in slant orientation. Stain each well with 0.1% crystal violet
and allowed to stand for 30 minutes or more. To the resulting setup after 30 minutes wash twice
with 1×PBS 1ml each time again carefully. Then, suspend the left over in 70% ethanol and take
the picture. Scan the plate with 570/nm wavelength, using the plate reader.
4.8 PISCIDINS AND THEIR COMPLEXES BIOFILM ASSAY
Well reduced 24 well plates, each well was filled with 2ml BHIS (glucose 1% and NaPO4
p H= 7.4). Except for the first row, inoculate with 20ul of starter culture of R20391 of biological
A, B, C, D, E & F respectively. No drug to the first column, 4uM of Cu2+ added to the second
column only, third column contain 2uM of P1 only while fourth contain mixture of 2uM p1 and
2uM Cu2+ fifth column was p3 alone and sixth well column contain the mixture of 4uM of Cu2+
and p3 each. The experimental setup was kept in incubator at 37OC in anaerobic environment for
24hrs. After 24hrs, washing procedure, discussed earlier for other biofilm and piscidin 1 and 3 was
carefully followed and plate reader used to scan the 24 well plate at 570/nm wavelength.
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4.9 Cu2+ BIOFILM ASSAY
P. aeruginosa and E. coli strains biofilm were grown in LB medium containing the
indicated concentrations of copper ions rather than supplemented BHIS. The protocols for biofilm
inoculation, growth, staining, and measuring were the same as those listed above. Duplicate plates
were set up for P. aeruginosa and E. coli strains. To account for slower growth in anaerobic
conditions, one plate was allowed to grow for 48 hours at 370C in the anaerobic chamber and one
was allowed to grow 24 hours at 370C aerobically.
4.10 TIME KILL ASSAY
Four biologically independent cultures of R20291 were grown overnight in TY medium
and then used to use to inoculate fresh TY medium. Culture were grown to mid-exponential phase.
The culture density was measured by monitoring optical density at 600 nm (OD600). At OD600
of 0.5-0.7, piscidin and/or copper were added at the indicated concentrations. At the indicated time
points, 20 µL aliquots of treated culture were added removed and serially diluted 10-folds in fresh
TY medium. Each sample was plated on BHIS plates at a 1:106 dilution and incubated
anaerobically at 370C for 24 hours. Colonies were enumerated
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CHAPTER 5
RESULTS AND DISCUSSIONS
5.1 MINIMAL INHIBITORY CONCENTRATIONS (MIC)
The following are the various results obtain for MIC of 630∆erm and R20291.
5.2 MIC FOR 630∆erm AND R20291
The minimum inhibitory concentration (MIC) is the lowest concentration sufficient to stop
the growths of microbes’ in-vitro.

This is determined by inoculating media containing a

concentration gradient of p1 and p3 peptides (from 0.063uM to 64uM) in a 96-well plate, with 20
µL of saturated starter culture of R20291 and 630∆erm C. difficile to a final volume of 200µL per
well. Uninoculated TY-medium was used as a blank. After 24 hours incubation, the plate reader,
using 630nm wavelength, measured the cell density in each well. Figure 7 showed the growth
curve for the two strains on three separate days. For the p1 the MIC was estimated on the curve to
be 4uM, although growth decline started at 2uM. The MIC for p3 was 8uM and growth decline
started at 4uM. The MIC determination for the two strains were carried out in the absence of
oxygen and at 370 C incubation.
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Figure 7: The MICs for p1 & p3 against both strains of C. difficile 630∆erm & R20291 through
measure of cell density after 24 hours. The figure above represents average three days data
acquisition plots
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5.3 MIC FOR R20291 USING DIFFERENT COPPER SALTS
It has previously been reported that piscidin peptides have stronger antibiotic activity when
complexed to copper ions (31). To investigate the effect of copper ions alone on C. difficile growth,
three different copper salts were tested against the virulent R20291 C. difficile strain. The
concentrations of the three copper salts employed ranges from 0 to 8uM. This is to test how those
copper concentrations affect the growth of C. difficile virulent strain. Figure 8 below, as at 8uM,
toxicity of copper(II) salts, no significant growth inhibitory effect and the bacteria growth was
stable above 1 of absorbance measured at 630/nm.

Figure 8: The copper concentration gradient for three copper(II) salts inhibitory effect
against the virulent strain of C. difficile.
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5.4 TIME KILL ASSAY
5.4.1 Time kill assay for p1, p3 and their copper complexes
The time kill assay was used to determine the killing rate of the peptides and their
complexes in both presence and absence of oxygen. Unlike MIC assays, time kill assays measure
the effects the peptides have on the C. difficile culture after they have been removed from the
bacterial cells by dilution. The time kill made use of sub-MIC concentrations of p1 and p3. The
concentrations used for p1 was 2µM and p3 was 4µM. To investigate potential synergy between
piscidins and copper, piscidins were tested in the presence and absence of equimolar CuSO4. The
method involved enumeration of colony forming unite per mL of culture (CFU/mL) of the treated
and non-treated cultures after plating for 24 hours at 370C in the incubator.
Enumeration of colonies revealed p1 alone had not significantly reduced CFU/mL at t=0
but the p1-Cu complex immediately reduced CFU mL by approximately 40% (Figure 9) in
comparison to NT. After 30 minutes, there was significant killing in comparison to untreated CFU.
Specifically, p1 vs p1+Cu only had low significant different at t=0 (p=0.0063) (Table 2) but as
time progressed no other time point showed any significant difference between the peptide alone
and its complex. The p3 and p3+Cu had no immediate impact after treatment because there was
less than 5% difference between NT, p3 and p3+Cu and the comparison showed no significant
difference at t=0 (Figure 10) (Table 3). Subsequently there were significant differences between
the p3 and p3+Cu to NT at all other time points. More than 50% reduction in CFU had occur in 30
minutes between the p3, p3+Cu to NT but, the peptide and its complex showed no significant
difference in them. At the four-hour point, no significant difference occurred between the p3 and
p3+Cu.

29

The data analyses (Table 2) showed there was initially no significant difference between
the samples treated with piscidin-1 (p1) and untreated (NT) samples. The samples treated with
p3+Cu complex had significantly lower CFU counts than the untreated samples (p < 0.001) and
samples treated with piscidin alone (p < 0.001) at the zero time point. After 30 minutes of
treatment, both p1 and p1+Cu were significantly different from the untreated samples (p < 0.001)
but showed no significant different from each other, meaning copper initially accelerated p1 killing
of the bacterial cells, but, the peptide alone quickly ‘caught up’ to the peptide-copper complex.
This same killing rate was observed at 2 and 4 hours’ time points after treatment.

Figure 9: The time kill curve for p1 and its copper complex lab mixture. The time kill
assay data which resulted into the above Figure 9 was an average of the peptides
antimicrobial activity carried out months apart
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Table 2: The data analysis of p1 and p1+Cu two ways ANOVA

Figure 10: The time kill curve for p3 and its copper complex for lab mixture
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Table 3: The p3 and p3+Cu time kill data analysis by two ways ANOVA

Table 3 above showed that at zeroth hour there was no significant difference in the three
conditions NT, p3 and p3 complex. As time progress the trends noticed in p1 and its complex
activities was the same at rest time points from half an hour to the fourth hour time point.
What was noticeable during data analysis, neither p1 nor p3 showed significant changes to
the killing rate when copper was added. This shows that adding copper in +2 oxidation states do
not increase the peptides’ activities “rate of vegetative cells killing”. This is directly contrary to
what was previously measured against E. coli in aerobic conditions (31). The time kill assay was
carried out several times over the course of four months.
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The copper concentration in the TY medium is 1.24 µM (Figure 14). This is low compared
to the amount of copper added in the assays. To account for the possibility that the extra copper
was being chelated by something else in the media and not forming complexes with piscidins, we
repeated the assays using pre-formed piscidin-copper complexes. Figure 11 and 12 show the
activities of the pre-formed peptides-copper’-complexes. In peptide p1+Cu and p1Cu complexes.
Where, p1+Cu represent the lab mixture and p1Cu is for pre-copper complex, respectively. For
any form of p1-copper complexes data analyses showed no significant difference in their rate of
killing (Figure 11). The p3 and its two different copper complexes showed significant difference
at starting point of t=0. This is likely due to slow chelation process between the peptide and copper
compound, in this case CuSO4. As time progressed, particularly at the 4-hour time point, there was
no significant difference in the killing rate of the two forms of peptide complexes. Figure 12
properly shows the curve for the two forms of p3 and its complexes.
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Figure 11: Comparative data curve for p1+Cu and p1Cu complexes. Where p1+Cu and p1Cu
represent the peptide copper mixed in the lab and pre-formed peptide-copper complexes.

Table 4: The data comparison of lab mixed peptides complex (p1+Cu) and pre-complex peptides (p1Cu)
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Figure 12: Comparative data plot for p3+Cu & p3Cu complexes. P3+Cu
and p3Cu are lab mixed and pre-formed peptide-copper complexes
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Table 5: The data comparison of lab mixed peptides complex (p3+Cu) and pre-complex peptides (p3Cu)

The time kill assay extended to the “sub-MICs” of p1 and p3 of copper(II) salts of 2uM
and 4uM respectively, in copper(II) alone samples treatment. At t=0 to t=4, time point as
previously done for the peptides and their complexes. The data curve (Figure 13) simply showed
that at those copper concentrations, there were no significant killing of the R20291 C. difficile
vegetative cells. The curve resulted from CFU/mL enumeration after 24 hours on each of the
plates. The curve showed that copper(II) at 2uM and 4uM had an initial impact, but, the vegetative
cells were able to recover as time went on.
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Figure 13: The time kill curve Cu2+ at 2uM & 4uM. This help to monitor
what happed to C. difficile vegetative cells’ growth at each time point
because of the copper concentration they are exposed to

Figure 14: Copper concentration/µM curve as determined by FAAS in three
different media. Concentration of Cu TY-medium is 1.24/µM, BHIS is 1.38/µM and
LB 2.18/µM respectively
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5.5 BIOFILM INHIBITORY ASSAY
5.5.1 BIOFILM ASSAY FOR PEPTIDES, COMPLEXES AND COPPER(II)
We measured the effect of piscidin peptides in the presence and absence of copper on C.
difficile biofilm formation. Biofilm were grown anaerobically at 37o C for 24 hours and then
quantitated by crystal violet staining. Figure 15 showed the amount of biofilm formation in the
treated and untreated 24-well plates, to a final volume of 2mL in each well. In contrast to previous
reports that piscidins disperse biofilm formation in anaerobic conditions, and that copper enhances
this effect, our results showed. Stimulatory effect in the treated wells, compared to the untreated
control. Figure 12 shows the highest biofilm formation in Cu2+ treated wells, to be higher than the
rest. This appear to be due to the copper, as the peptides did not further increase biofilm formation.
Table 6 showed that the amount of untreated (NT) biofilm formed had no significant
difference to the two peptides alone. More biofilm formation in the p1+Cu complex treated wells
resulted into significant difference (p < 0.001) when compared to the NT and p3+Cu were not
significant. However, any data comparison to copper(II) salt (CuSO4) alone biofilm formation,
showed significant difference (p < 0.001), consistently and convincingly. Other comparison not
against CuSO4 treated ones are not affirmative, but, when compared with the copper salt alone its
straight forward significant difference.
This result prompted a lot of questions rather than answers. We continued to investigate
the metallic oxidative stress response in C. difficile virulent strain (R20291) and high biofilm
forming mutant strain (RT527). The comparison of p1+Cu to p3+Cu showed significant difference
(p = 0.0059), this may be because of p1 and its complex having more of its bactericidal activities
to be membrane specific rather than nuclease.
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Figure 15: The amount of biofilm treated and the untreated control. Treated ones are
peptides, peptide-copper complexes and copper(II) alone. NT in this figure represents
the untreated control
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Table 6: The data analyses of peptides and their complexes with copper salt alone
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5.6 BIOFILM METALLIC STIMULATORY EFFECT
We measured the effect various copper(II) salts on biofilm formation in C. difficile R20291
and RT527, or R20291 pDccA, a strain with elevated c-di-GMP levels and high biofilm formation
(33). The C. difficile strains were exposed to gradient concentrations of copper(II) salts. These
concentrations appear to stimulate more biofilm formation, in direct relation to increased
concentration. The biofilm production almost showed linear proportionality (Figure 16 and 17) the
curve of the two strains in the increase Copper(II) concentration.
Table 7 and 8 respectively showed no statistically significant differences due to copper
treatment. The figures however, showed trend towards increase biofilm formation response to
increases in copper(II) salt concentrations when compared to untreated well. In RT527, known for
its large biofilm formation capability, the copper(II) salt gradient concentration was from 0.25/µM
to 2/µM. However, in further investigations the concentration level may be raised, but at these
concentrations the figure showed the trend, but differences were not statistically significant. The
trend did concur with that seen in the initial piscidin with or without copper experiments (Figure
12).
Investigations continued with the usage of other copper(II) salts, CuSO4, CuCl2 and
Cu(NO3)2 respectively. The stimulatory effect appeared to be the same in R20291 and RT527.
Figure 18 shows the different copper(II) salts curves. The figure showed a mild stimulatory effect,
but, according to the data analyses (Table 9), there were no significant differences in the amount
of biofilm formed. Notably, addition of any type of copper(II) salts do not inhibit biofilm formation
in C. difficile rather it appears to stimulate more biofilm formation in all experimental results as
seen in figure 18. So, the anaerobic compared to aerobic antimicrobial activities of copper and
other transition metal merit further investigations.
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Figure 16: The copper salt (Cu2+) alone concentration gradient for biofilm
quantitative analysis of R20291 C. difficile strain
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Table 7: Copper salt alone biofilm data formation analyses
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Figure 17: The copper(II) salt (Cu2+) biofilm quantitative for RT527 C. difficile strain
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Table 8: The data analyses of gradient concentrations of copper(II) salts on RT527 C. difficile strain
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Figure 18: The different Cu2+ biofilm quantitative effect curve. Each bar from NT to 4uM
represent CuSO4, CuCl2 & Cu(NO3)2 respectively and NT represent the untreated control
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Table 9: The data analyses of different copper salt biofilm formation
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CHAPTER 6
CONCLUSIONS
The characterization of the Clostridium difficile oxidative stress response and antimicrobial
effect of piscidin peptides and complexes on these bacteria was determined in anaerobic
conditions. The p1 has a lower MIC (4µM) than p3 (8µM) but both the piscidins are active
antimicrobial peptides in anaerobic conditions against Clostridium difficile. Their antimicrobial
activities include growth inhibition and permanent bacterial killing. The killing rate in the absence
of oxygen invitro gave these confirmatory results. In the time kill assay, p1 and its copper complex
had started killing immediately after treatment while it takes 30 minutes for p3 and its copper
complex to show any bactericidal activities. The estimation of number of colony forming unite
(CFU) at each time points till the fourth hour, was that the total number of CFU in p1 and its
complex compared to p3 and its complex. As a result of these data analyses p1 appear to be a
slightly better antimicrobial agent than p3 in an anaerobic environment. This is consistent with
what was previously observed aerobically but the lack of synergy between piscidins and copper is
novel to this work.
In the absence of piscidin, copper(II) alone at the sub-MICs of both peptides’ p1 and p3
which were 2uM and 4uM sub-MICs respectively. At these concentrations there was no significant
killing of the bacteria. Within half hour exposure of the bacteria, the metallic oxidative stress
inferred from the CFU plot at this time point, showed lower number of viable cells. However, the
bacteria cells were able to overcome the stress within two hours and the CFU showed they had
recovered from the oxidative stress.
The peptides in comparison to their complexes show no significant difference in their
bacteria killing rates. So, the bactericidal activities of both peptides are not enhanced by the
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presence of copper(II) ion as the time progressed in the anaerobic environment. This is a direct
contrast to what was observed in Gram-positive and Gram-negative bacteria in aerobic
environment by Daben J. Libardo et al in 2017.
The lab mixed and pre-complex “piscidin complexes” had approximately the same end
results in their killing rates, confirming that the peptides are not failing to form the complexes in
those conditions tested. This result confirmed that the mixed copper(II) salts are not used up by
any other C. difficile metabolic activities and they got to the targets in the media. This means that
while the piscidin peptides and copper ions can both induce stress in C. difficile, the peptides and
copper ions do not exhibit the same synergy in an anaerobic environment that they do aerobically.
The biofilm prevention assay appears to have different result in anaerobic environment to
the bacteria biofilm dispersal assay in aerobic environment as reported. It was previously report
that modest inhibitory activities occur when peptides alone are used for biofilm inhibitory assay.
The same assay in the presence of peptide complex, showed stronger biofilm clearance was
reported in aerobic condition. In anaerobic conditions peptides and their complexes do not show
any biofilm inhibitory effect, but, the peptide complexes and metal alone at sub-MICs tend to show
stimulatory effect. So, C. difficile appears to respond to oxidative stress through formation of more
biofilm to protect themselves from the reactive oxygen species generated in the oxidative stress
process. The investigations up to this point support the conclusion that the peptides’ antimicrobial
mechanisms and metallic ion interactions appear to be different based on their environment and
their targets. So, drugs design based of these peptides, the designer must keep in mind the
environment and the physiological target of the peptides. The aerobic and anaerobic biofilm
formation in E. coli strains are really promising and this among others will be forming the bases
of my PhD research, in fall.
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